Cargando…
Pulmonary and Peritoneal Tuberculosis Associated with Tumor Necrosis Factor-Alpha Inhibitor Use: A Case Report and Review of the Literature
The association between the use of tumor necrosis factor-α inhibitors and the increased risk of granulomatous infections, especially tuberculosis, has been well documented. Given the rapidly expanding list of inflammatory conditions for which tumor necrosis factor-α inhibitors are receiving FDA appr...
Autores principales: | Tipirneni, Niharika, Siegel, Marc O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529438/ https://www.ncbi.nlm.nih.gov/pubmed/23304607 http://dx.doi.org/10.1155/2012/598634 |
Ejemplares similares
-
Production of tumor necrosis factor-alpha by alveolar macrophages from patients with pulmonary tuberculosis.
por: Kim, S. J., et al.
Publicado: (1991) -
Tumor Necrosis Factor-Alpha and Interleukin-1 Alpha as Predictors of Survival in Peritonitis: A Pilot Study
por: Afuwape, Oludolapo Ola, et al.
Publicado: (2018) -
A human inhibitor of tumor necrosis factor alpha
Publicado: (1988) -
Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
por: Callejas-Rubio, José Luis, et al.
Publicado: (2008) -
The adverse drug reactions to tumor necrosis factor alpha inhibitor
por: Park, Hye-Kyung, et al.
Publicado: (2014)